The Food and Drug Administration’s 2023 approval of the first over-the-counter birth control pill[1], called Opill, broadened the options[2] for people seeking to prevent pregnancy.
On March 4, 2024, the pill’s manufacturer, Perrigo Company, announced that
 Regulators have ordered the centre to halt any new procedures while an investigation continues.
Regulators have ordered the centre to halt any new procedures while an investigation continues.